These effects occur almost simultaneously after surgery and may offer a paradigm to identify the profound mechanisms driving improvements in glucose metabolism, insulin resistance, gut hormone release, microbiota and adipokine modulation [32–35]; which may offer a resolution of obesity-linked cardiac dysfunction. The gene discussed is INS; the disease is Obesity.